Ajanta Pharma Ltd. benchmarking: Performance to industry peers

Financial

	Ajanta Pharma	Glaxosmithkline Phar	Gland Pharma
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	75.0 .	n/a	388.0 .
Number of ANDA's Approved By USFDA	56.0 .	n/a	337.0 .
Domestic Sales Growth - YoY	7.5 %	8.9 %	n/a
R&D as a % of Total Sales	5.0 %	0.07 %	4.0 %
Financials
5 yr Average ROE	21.93 %	45.03 %	12.02 %
5yr average Equity Multiplier	1.33	1.87	1.15
5yr Average Asset Turnover Ratio	0.86	0.92	0.51
5yr Avg Net Profit Margin	19.12 %	27.88 %	20.79 %
Price to Book	9.53	18.57	3.92
P/E	40.85	40.65	39.56
5yr Avg Cash Conversion Cycle	-104.16 Days	-107.65 Days	69.81 Days
Inventory Days	45.5 Days	47.69 Days	118.26 Days
Days Receivable	49.07 Days	24.45 Days	99.92 Days
Days Payable	180.12 Days	155.09 Days	107.43 Days
5yr Average Interest Coverage Ratio	103.83	556.84	183.05
5yr Avg ROCE	28.04 %	48.35 %	16.55 %
5yr Avg Operating Profit Margin	25.85 %	27.99 %	29.26 %
5 yr average Debt to Equity	0.01	0.0	0.01
5yr CAGR Net Profit	8.18 %	-9.37 %	-6.87 %
5yr Average Return on Assets	16.5 %	24.4 %	10.65 %
Shareholdings
Promoter Holding	63.48 %	75.0 %	51.83 %
Share Pledged by Promoters	22.53 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.73 %	0.0	-6.03 %
Change in Mutual Fund Holding (3 Yrs)	5.03 %	0.62 %	11.53 %

	Ajanta Pharma	Glaxosmithkline Phar	Gland Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Vaccines 0 Pharmaceuticals 0 Injectables 0	Product Wise Break-Up Pharmaceutical 0 Vaccines 24.0 Pharmaceutical 76.0 Injectables 0	Product Wise Break-Up Pharmaceutical 0 Vaccines 0 Pharmaceutical 100.0 Injectables 0
Segment Break-Up	Segment Break-Up Others 100	-	-
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Dermatology 22.0 Respiratory 0 Hormones 0 Pain/Analgesics 0 Vaccines 0 Anti-Infectives 0 Vitamins/Minerals/Nutrients 0 Others 78.0	Therapeutic Area Wise Break-Up - Domestic Hormones 8.91 Pain Management 11.96 Vaccines 12.64 Dermatology 30.55 Respiratory 3.95 Vitamins / Minerals / Nutrients 6.47 Anti-Infective 22.25 Others 3.27	-
Location Wise Break-Up	Location Wise Break-Up USA 35.74 India 28.59 Asia Pacific 19.39 Africa 16.28 Rest of the World 0 Core Markets 0 Canada, Australia & New Zealand 0 Australia 0 Canada 0 Europe 0	Location Wise Break-Up USA 0 India 98.64 Rest of the World 1.36 Core Markets 0 Asia Pacific 0 Canada 0 Australia 0 Europe 0 Canada, Australia & New Zealand 0 Africa 0	Location Wise Break-Up USA 56.27 India 3.84 Rest of the World 0 Core Markets 71.57 Asia Pacific 0 Canada 0 Australia 0 Europe 21.88 Canada, Australia & New Zealand 3.37 Africa 0
Asset Break-Up	Asset Break-Up India 97.73 Africa 1.14 USA 0.64 Asia Pacific 0.49	-	-